RESUMO
Verificar o efeito da prática de 10 sessões de caminhada sobre a qualidade de vida e auto-eficácia de mulheres com Síndrome da Fibromialgia (FM). Método: Participaram do estudo oito mulheres com diagnóstico clínico de FM, selecionadas de forma não-probabilística intencional. As avaliações foram realizadas antes e após 10 sessões da prática de caminhada. Os instrumentos utilizados foram o Questionário Sócio-demográfico e Clínico, o Questionário de Impacto da Fibromialgia e a Escalade Auto-eficácia para Dor Crônica. Após a verificação da normalidade através do teste Shapiro-Wilk, osdados foram tratados com estatística descritiva (freqüência, média e desvio padrão) e inferencial (teste t de Student e teste de Pearson). Resultados: A média de idade das participantes foi de 49 anos (+12,8), o impacto da síndrome da fibromialgia na qualidade de vida no pré-teste foi de 53,64 pontos e no pós-teste de 51,99 pontos (p=0,73) e a Auto-eficácia no pré-teste foi de 147,57 pontos e no pós-teste foi de 172,27 pontos (p=0,15). Em relação aos três domínios deste questionário, apenas o domínio da Auto-eficácia para lidar com outros sintomas apresentou diferença significativa entre o pré e pós-teste (p=0,02). Houve correlação negativa pós-teste (r=-0,72; p=0,042) entre o impacto da fibromialgia e a auto-eficácia. Conclusão: Apesar do curto período de intervenção realizado, a prática de caminhada melhorou o domínio da auto-eficácia para lidar com outros sintomas em mulheres com FM. Em relação à qualidade de vida, não ocorreram melhoras.
Objective: Verify the effect of practical of 10 walk sessions on the quality life and self efficacy of women with Fibromyalgia Syndrome (FM). Method: eight women with clinical diagnosis of FM had participated of the study. The evaluations were before and after 10 sessions of the practical of walking. The used instruments were the Questionário Sócio-Demográfico e Clínico, The Fibromyalgia Impact Questionnaire, and the Chronic Pain Self-efficacy Scale. After the verification of normality through the Shapiro-Wilk test, the data were dealt with descriptive statistics (frequency, average and deviation standard), test t and Pearson. Results: The average of age of the participants was of 49 years (±12,8), the impact of the fibromyalgia syndrome in the quality of life in the daily pay-test was of 53,64 points and in the after-test of 51,99 points (p=0,73) and the self-efficacy in the daily pay-test was of 147,57 points and in the after test was of 172,27 points (p=0,15). In respect to the three domains of this questionnaire, only the domain of the self-efficacy to deal with other symptoms presented significant difference between the daily pay and after-test (p=0,02). After test had negative correlation (r=-0,72; p=0,042) on the impact of the fibromyalgia and self-efficacy. Conclusion: Although the small number of accomplished sessions (10 sessions), the practical of walking improved the domain of the self-efficacy to deal with other symptoms in women with FM. In the analysis of the quality of life, had not occurred improvements.
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Eficácia , Exercício Físico , Fibromialgia , Qualidade de Vida , Caminhada , Intervenção em Crise , Doença , DorRESUMO
OBJECTIVE: Differences in postpartum depressive symptomatology (PPDS) among an international sample of 892 women from nine countries representing five continents were explored. METHOD: Edinburgh Postnatal Depression Scale (EPDS) and Beck Depression Inventory (BDI) were used to assess PPDS among a convenience sample that completed the two questionnaires twice, yielding a total of four sets of scores per subject. Women sampled were primiparae with no obstetrical complications, and had a healthy baby. Depression history and therapy were ruled out as exclusion criteria. RESULTS: Mean scores for EPDS and BDI varied across sites at both time points (P value<.001). European and Australian women had the lowest levels of PPDS, USA women fell at the midpoint, and women from Asia and South America had the highest depressive symptom scores. The moderate concordance between the EPDS and BDI suggested that the measures have complementary uses for screening and assessment. CONCLUSION: Utility of EPDS and BDI for yielding profiles of postpartum women's depressive symptomatology was demonstrated. Further research to validate depressive symptom measures with diverse international populations is indicated.